People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

17 Apr 2014
Price Change (% chg)

$0.04 (+1.43%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Deshpande, Milind 

Brief Biography

Dr. Milind S. Deshpande, Ph.D., is President, Chief Executive Officer, Director of Achillion Pharmaceuticals Inc. Prior to joining Achillion in September 2001, Dr. Deshpande was Associate Director of Lead Discovery and Early Discovery Chemistry at the Pharmaceutical Research Institute at Bristol-Myers Squibb, a pharmaceutical company, from 1991 to 2001, where he managed the identification of new clinical candidates to treat infectious and neurological diseases. From 1988 to 1991, he held a faculty position at Boston University Medical School. Dr. Deshpande received his Ph.D. in Organic Chemistry from Ohio University, following his undergraduate education in India.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
577,372 -- 929,917 1,507,290

Options Compensation

  Quantity Market Value
Exercisable 485,000 --
Unexercisable -- --
Exercised 15,937 139,342.00
Name Fiscal Year Total

David Scheer


Milind Deshpande


Mary Kay Fenton


Gautam Shah


David Apelian


Joseph Truitt

As Of 30 Dec 2012
Search Stocks